US Stock Market Move | Soros reportedly shorting Carvana (CVNA.US), causing it to drop more than 6% at one point.

23:29 02/01/2025

Carvana's stock price has fluctuated significantly, currently up more than 2%, after previously falling more than 6%.

In Thursday's midday trading on the US stock market, the stock price of used car retailer Carvana (CVNA.US) fluctuated significantly, rising over 2% after previously falling more than 6%. On the news front, short-selling firm Hindenburg Research announced that it was shorting Carvana. Hindenburg Research stated that after four months of research, they found that Carvana sold $800 million in loans to potentially undisclosed related parties, engaged in accounting manipulation, and at the same time, insiders cashed out billions of dollars in stock.

SHINEWAY PHARM (02877) had a revenue of 2.415 billion RMB in the first three quarters, a decrease of 16.3% year-on-year.

FIRST PACIFIC (00142) has completed the proposed demerger of MAYNILAD WATER SERVICES, INC. and will independently list on the Philippine Stock Exchange.

BOAN BIOTECH (06955): Two types of Dexu Monoclonal Antibody Injections have been accepted for market approval in the United Kingdom.

SHINEWAY PHARM (02877) had a revenue of 2.415 billion RMB in the first three quarters, a decrease of 16.3% year-on-year.

FIRST PACIFIC (00142) has completed the proposed demerger of MAYNILAD WATER SERVICES, INC. and will independently list on the Philippine Stock Exchange.

BOAN BIOTECH (06955): Two types of Dexu Monoclonal Antibody Injections have been accepted for market approval in the United Kingdom.